&w=3840&q=100)
Can Mounjaro transform obesity care? ₹50 crore sales in three months
New Delhi
Mounjaro, Eli Lilly's drug for treating type-2 diabetes and supporting obesity management, has seen rapid uptake in India, recording ₹50 crore in sales within just three months of its launch in March 2025, The Economic Times reported, citing the data from PharmaTrac.
According to PharmaTrac, an online database and analytical tool that provides insights into the Indian pharmaceutical market, monthly sales surged from ₹13 crore in May to ₹26 crore in June, coinciding with the India launch of rival drug Wegovy by Novo Nordisk.
In volume terms, Mounjaro's sales rose more than sevenfold since launch, reaching 88,000 units in June alone.
What is Mounjaro, and why is it so much in news?
Mounjaro (generic name tirzepatide) is an injectable drug developed by US pharmaceutical giant Eli Lilly. Initially approved to treat type-2 diabetes, it's gained global fame for its dramatic weight-loss effects, so much so that it's now considered a game-changer in the fight against obesity.
Its mechanism works by mimicking two gut hormones, GLP-1 and GIP, which help regulate blood sugar and suppress appetite.
Why is Mounjaro's growth so explosive?
A mix of factors is fuelling Mounjaro's acceptance in India:
Weight-loss buzz: Global success stories and celebrity endorsements have turned it into a household name among those battling obesity.
Medical trust: It's been approved by global regulators, including the US Food and Drug Administration (US FDA) for both diabetes and weight loss.
How does Mounjaro compare with its rivals?
While Ozempic (generic name semaglutide) and Wegovy (also semaglutide), both made by Novo Nordisk, focus on GLP-1 action, Mounjaro adds an extra layer by also mimicking GIP. This 'twin hormone' approach has shown superior weight-loss outcomes in clinical trials.
Who can use Mounjaro, and is it safe?
Mounjaro is prescribed for adults with type-2 diabetes or obesity-related complications, and it's not meant for casual or cosmetic weight loss. Doctors typically recommend it for:
Adults with type-2 diabetes
Patients with BMI ≥30, or
BMI ≥27 with other health conditions (like high blood pressure, cholesterol, among others)
Strict medical supervision is required during the treatment. Like all powerful drugs, it can have side effects, including nausea, vomiting, and potential thyroid issues. For more health updates, follow #HealthWithBS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
7 hours ago
- India Today
IIM Ahmedabad and Novo Nordisk India partner to combat obesity and enhance healthcare systems
Novo Nordisk's weight loss medication, Wegovy, has also made its debut in India, marking a significant milestone in the country's battle against obesity. On July 8, 2025, the Indian Institute of Management Ahmedabad (IIMA) and Novo Nordisk India Pvt Ltd (NNIPL) entered into a strategic collaboration aimed at enhancing the healthcare ecosystem in India. The five-year partnership will focus primarily on addressing non-communicable diseases (NCDs), with a particular emphasis on combating obesity. Novo Nordisk's weight loss medication, Wegovy, has also made its debut in India, marking a significant milestone in the country's battle against obesity. The MoU sets out a broad framework for joint action in three key areas: strengthening healthcare systems, advocating for policy changes, and advancing health economics. This includes co-developing models for obesity clinics, producing educational resources for healthcare professionals, and designing data-driven public health policies. The partnership will also encompass research initiatives that evaluate the economic consequences of obesity on personal health, workforce productivity, and the national healthcare system. These research activities aim to highlight the broader financial impact of obesity on society and help inform future policy decisions. In addition to research, the collaboration will involve publishing joint papers in association with government agencies, rolling out pilot outreach initiatives, and exploring the potential of telemedicine in managing NCDs, particularly in rural and underserved regions. The aim is to generate valuable insights that can both shape healthcare policies and improve service delivery across the country. The IIMA Endowment Fund (IIMAEF), which supports strategic partnerships and philanthropic endeavours, played a pivotal role in facilitating this collaboration. Through the fund, IIMA is able to leverage its academic resources to address critical societal issues such as public health. This partnership is designed to integrate educational, corporate, and research capabilities to create scalable healthcare models for managing NCDs, with a central focus on obesity. It is expected to bring long-term improvements in both health outcomes and policy frameworks across India.
NDTV
a day ago
- NDTV
Internet Calls Cinnamon A Natural Fat-Burner. Does It Actually Help In Weight Loss?
In the past few years, as weight loss drugs, medicines, and supplements have flooded the market, many people have been returning to kitchen basics for natural aids to lose weight. A recent survey found that 87% Indians wanted to know more about non-drug-assisted weight-loss methods, even as injectibles like Wegovy and Mounjaro make their entry in India. The trend of going back to kitchen basics to lose weight appears to be driven by influencers and even Bollywood celebrities. The latest ingredient gaining popularity for weight loss is cinnamon, and one of its fans is actor Harshvardhan Rane, whose old video recently resurfaced, in which he calls cinnamon his personal 'fat burner'. View this post on Instagram A post shared by Ask Health Guru (@askhealthguru) Cinnamon AKA Dalchini Cinnamon, or dalchini as it's commonly known in India, is a fragrant spice derived from the inner bark of trees belonging to the Cinnamomum genus. In Indian households, dalchini has long been used in everything from masala chai and biryanis, to Ayurvedic remedies for colds, coughs, and digestive issues. Traditionally valued more for its medicinal properties than its flavour alone, dalchini is often found in kadhas, herbal teas, and even post-meal spice blends to aid digestion. While most Indians are familiar with the robust, slightly spicy flavour of Cassia cinnamon (the common type sold here), its milder and sweeter cousin Ceylon cinnamon, also known as "true cinnamon", is gaining popularity for its health benefits and lower coumarin content. Coumarin is an anticoagulant derived from certain plants, and can also be made in a laboratory. What Makes Cinnamon So Special? Dr Archana Batra, Dietician and Certified Diabetes Educator, explains that cinnamon has long been used both in Indian foods and in traditional remedies for its antioxidant, antibacterial, and digestive benefits. Scientifically, it plays a role in: Regulating blood sugar "Fluctuating blood sugar levels can lead to frequent cravings, especially for sweets and carbs. Cinnamon helps keep this in check, making it easier to manage weight," says Dr Batra. This stability helps curb hunger pangs and manage insulin spikes. Boosting metabolism The key compound here is cinnamaldehyde, which gives cinnamon its distinctive flavour and also stimulates metabolism. "While cinnamon alone won't lead to drastic weight loss, it can be a valuable metabolic booster when paired with a healthy diet and lifestyle," she adds. Reducing inflammation Chronic inflammation is often linked to weight gain and metabolic issues. With its rich antioxidant profile, cinnamon helps combat that. Can Cinnamon Really Help You Lose Weight? According to Khushboo Jain Tibrewala, Nutritionist and Founder of The Health Pantry, cinnamon may not be a miracle, but it's certainly helpful. "It helps your body handle carbs and sugars better, which indirectly supports fat metabolism and appetite control," she adds. She elaborates on how it works: Improves insulin sensitivity: Particularly with Ceylon cinnamon, compounds like cinnamaldehyde and polyphenols help reduce fat storage. Slows gastric emptying: Making you feel fuller for longer, which can reduce overall calorie intake. Supports post-meal blood sugar control:"The traditional Indian habit of having cinnamon tea after meals actually has scientific merit," she notes. Citing a 2020 study published in Lipids in Health and Disease, Khushboo points out that 3 gram of cinnamon taken daily over 3 months led to lower blood glucose, better insulin sensitivity, and improved cholesterol levels. But she warns, "Cinnamon is a support tool, not magic. It works best when paired with whole foods, regular movement, adequate sleep, and stress control." What The Research Really Says Vidhi Chawla, dietician and founder of Fisico Diet and Aesthetic Clinic, also seems to agree with other experts. "The primary scientific reason cinnamon is linked to weight loss revolves around its impact on blood sugar regulation and insulin sensitivity," she says. By mimicking insulin, it helps cells absorb glucose more efficiently, thereby stabilising sugar levels and reducing cravings. Vidhi also notes the effect of cinnamon on metabolism. "Cinnamaldehyde has been shown to increase the activity of genes and enzymes involved in fat metabolism. It may also have mild thermogenic properties, helping the body burn slightly more calories," she adds. She highlights its other perks like: Antioxidant support: Polyphenols in cinnamon help reduce inflammation, which is often linked to obesity. Heart health: Cinnamon may lower total and LDL cholesterol. Appetite suppression: Thanks to its blood sugar-balancing effects and fibre content, it promotes satiety. The Dos And Don'ts Of Using Cinnamon For Weight Loss All three experts agree on one crucial point: quality and quantity matter. "For daily use, I always recommend Ceylon cinnamon - safer and gentler on the body compared to Cassia, which is higher in coumarin and can be toxic in excess," says Khushboo. There can be side effects of consuming too much Cassia cinnamon or using high-dose supplements (which we will get to in a bit). So, here's how to use cinnamon instead: One fourth to half a teaspoon per day is usually safe Add it to warm water, teas, oats, smoothies, or fruits Avoid capsules or supplements unless under the guidance of a qualified practitioner Side Effects Even though experts point out that while generally safe in typical culinary amounts, excessive consumption, especially of Cassia cinnamon (the most common type), can pose risks due to its coumarin content. According to Vidhi, it can cause: Liver Damage: High doses of coumarin can be toxic to the liver. Individuals with pre-existing liver conditions should be particularly cautious. Low Blood Sugar (Hypoglycemia): If consumed in very large amounts, particularly by those on diabetes medication, it could potentially lower blood sugar too much. Mouth Sores: Some people may experience allergic reactions, leading to mouth sores (cinnamon stomatitis). Breathing Problems: Inhaling dry ground cinnamon can cause irritation, coughing, or even aspiration pneumonia. Remember Cinnamon isn't a quick fix or a miracle solution - but it's certainly not just hype either. Its benefits are rooted in both traditional wisdom and modern science (which is rare). Whether you're trying to curb cravings, balance your blood sugar, or boost your metabolism gently, cinnamon can play a supportive role. But it won't single-handedly melt away fat.
Indian Express
a day ago
- Indian Express
IIM Ahmedabad, Novo Nordisk India sign MoU to address obesity and strengthen healthcare systems
The Indian Institute of Management Ahmedabad (IIMA) and healthcare company Novo Nordisk India Pvt Ltd (NNIPL) have signed a Memorandum of Understanding (MoU) on July 8, 2025, marking the beginning of a five-year strategic partnership. The collaboration will focus on strengthening India's healthcare ecosystem, with a particular emphasis on non-communicable diseases (NCDs), especially obesity. Novo Nordisk's Wegovy, the blockbuster weight loss drug, debuts in India Under the agreement, the two institutions will co-develop programmes across three key areas — health system capacity building, policy advocacy, and health economics. The collaboration will involve the development of model frameworks for obesity clinics, creation of educational content for healthcare professionals and stakeholders, and formulation of data-backed public health policies. IIM Ahmedabad welcomes 2025–27 PGP batch of 414 students Additionally, the initiative will include research projects that study the economic impact of obesity on individual health, workforce productivity, and the broader healthcare system and economy. The partnership outlines plans for joint research activities, including publication of papers in collaboration with government bodies, conducting pilot outreach programmes, and evaluating the role of telemedicine in managing NCDs in underserved areas. These initiatives aim to generate actionable insights to support both policy-level changes and improvements in healthcare delivery. In its statement, the institute said that the IIMA Endowment Fund (IIMAEF), which facilitates partnerships and philanthropic engagement, played a key role in shaping this collaboration. The fund supports initiatives that align with the institute's objective of using academic and research capabilities to address societal challenges, including public health. IIM Ahmedabad Placements 2025: Highest Package, Average Package, Summer Placements and Top Recruiters By integrating educational, corporate, and research resources, the partnership aims to contribute towards developing scalable healthcare models for NCD management, with obesity as a central focus. The effort is intended to support long-term improvements in health outcomes and policy-making in India.
